Why I Stopped Recommending Meniscus Surgery for Degenerative Tears
- 6 hours ago
- 5 min read
By Dr. Jeffrey Peng, MD · Published May 9, 2026 · 7 min read
Watch the Full Video
If you are 40 or older and have been told you need surgery for a degenerative meniscus tear, the evidence has shifted dramatically in the past few years — and the most recent long-term data may change your mind. The New England Journal of Medicine has just published 10-year follow-up results from a sham-controlled trial of arthroscopic partial meniscectomy, and the findings confirm what many sports medicine physicians, myself included, have been telling patients for years. In my practice, I no longer recommend meniscus surgery for degenerative tears in most cases. Here is why — and what I recommend instead.
What Did the 10-Year Sham-Controlled Trial Show?
The FIDELITY trial enrolled adults aged 35 to 65 with MRI-confirmed degenerative meniscus tears. Half were randomized to receive arthroscopic partial meniscectomy. The other half underwent a sham procedure — anesthesia, incisions, and the appearance of surgery without any tissue removal. Patients did not know which group they were in. Ten years later, the investigators reported the long-term outcomes.
On every meaningful patient-reported measure, the surgery group did no better than the sham group. Pain scores were no different. Knee function was no different. The ability to return to normal activities was no different. In fact, only 71% of patients in the surgery group reported they were able to return to normal activities at 10 years, compared with 85% in the sham group. Patient-reported satisfaction was lower in the surgery group. Meniscal symptoms and overall disability scores were lower in the surgery group as well. After a decade of follow-up, every meaningful outcome either showed no benefit from surgery or favored the patients who received the sham procedure.
Did Meniscus Surgery Increase the Risk of Knee Replacement?
This is the finding that fundamentally changed how I counsel patients. The investigators tracked serial X-rays over the full 10 years to monitor osteoarthritis progression — joint space narrowing, bone spur formation, and overall radiographic arthritis scores. The surgery group had higher rates of osteoarthritis progression than the sham group, with worse arthritis scores at 10 years.
They then tracked how many patients in each group went on to require a total knee replacement. In the sham group, 4% needed a knee replacement at 10 years. In the surgery group, that number was 12%. Patients who received arthroscopic partial meniscectomy were three times more likely to end up needing a knee replacement than patients who received a fake surgery.
For years, the conversation around meniscus surgery has focused on short-term pain relief and the appeal of a quick fix. The 10-year data tell a different story. Whatever short-term benefit patients perceive comes with a measurable long-term cost: accelerated arthritis progression and a tripling of the risk of needing a knee replacement.
Why Does Removing Meniscus Tissue Make Things Worse?
These findings are entirely consistent with what we know about how the meniscus functions. The meniscus is a wedge-shaped cushion that distributes load across the knee joint and protects the underlying cartilage from compressive forces. Even a torn or frayed meniscus continues to perform this shock-absorbing function. When a surgeon trims, debrides, or removes a portion of meniscus tissue — even a small piece — the load distribution across the knee changes. The articular cartilage that is supposed to be padded and protected by the meniscus now takes on more direct force. Over the course of years, that increased mechanical stress accelerates cartilage wear and arthritis progression.
In other words, what looks like a minor cleanup procedure on arthroscopic video is actually a structural alteration to one of the most important load-bearing tissues in the knee. The 10-year FIDELITY data confirm that this alteration matters.
What Is the Non-Surgical Alternative for Degenerative Meniscus Tears?
If meniscus surgery is no longer the answer for most degenerative tears, what should patients be doing instead? Physical therapy is always a reasonable starting point. For patients whose symptoms persist despite a structured rehab program, platelet-rich plasma (PRP) injections have emerged as a compelling alternative — and the data continue to grow stronger.
A recent systematic review published in the Journal of Cartilage and Joint Preservation examined how PRP performs as a treatment for degenerative meniscus tears. Patients treated with PRP demonstrated greater than 80% surgery-free survival at mid-term follow-up. More than 8 out of 10 patients with degenerative meniscus tears who received PRP avoided surgery entirely. Pain improved. Function improved. And in a subset of studies, follow-up MRI imaging showed actual healing of the meniscus tissue itself.
In one of the largest individual studies included in the review, researchers treated nearly 400 patients with degenerative meniscus tears using ultrasound-guided PRP injection directly into the meniscus tear, combined with a separate PRP injection into the knee joint itself. At 5-year follow-up, more than 90% of these patients had not needed surgery. That is a remarkable durability of effect for a single-day, minimally invasive treatment.
What Does This Look Like in Clinical Practice?
Two years ago, I saw a 42-year-old patient who had been diagnosed with a degenerative meniscus tear on MRI. He had already seen one orthopedic surgeon who recommended physical therapy as a first step. He completed more than 6 months of formal therapy. He improved, but he still could not get back on the tennis court. He saw two more orthopedic surgeons after that, and both recommended arthroscopic meniscus surgery.
He came to me looking for another option. We performed a single PRP procedure under ultrasound guidance — one injection directly into the meniscus tear, and a second into the joint itself, both at the same visit. At his 3-month follow-up, his pain and function had improved substantially. By 6 months, he was back to playing tennis, cycling with his kids, and hiking with his wife. His swelling was gone. The mechanical catching had resolved. He had no functional limitations.
I saw him again recently for a completely unrelated issue. When I asked how his knee was doing, he gave me a slightly surprised look and said he simply does not think about it anymore. That is the goal. The objective is not to avoid surgery for its own sake or to manage pain indefinitely — it is to give patients their lives back without accelerating their arthritis or tripling their risk of a future knee replacement.
The Bottom Line on Meniscus Surgery for Degenerative Tears
The 10-year FIDELITY data should change how this conversation happens in orthopedic and sports medicine clinics. For patients in their 40s, 50s, and 60s with degenerative meniscus tears — meaning the kind associated with normal age-related wear rather than acute traumatic injury — arthroscopic partial meniscectomy provides no meaningful long-term benefit over a sham procedure, and it accelerates arthritis progression while tripling the risk of eventual knee replacement.
Not all PRP is the same, however. The platelet dose delivered, the preparation technique, and the injection protocol all matter — and these variables are part of why outcomes in the published literature can look so different from one study to the next. If you are considering PRP for a meniscus tear, work with a physician who reports platelet doses, uses ultrasound guidance, and can target the meniscus tear directly rather than only injecting into the joint.
If you are weighing surgery for a degenerative meniscus tear, I would strongly encourage a conversation about non-surgical options first. To schedule a consultation, you can reach my Campbell, California sports medicine clinic through my website.
References
1. Kalske R, Sihvonen R, Paavola M, et al. Arthroscopic partial meniscectomy for degenerative tear — 10-year outcomes. N Engl J Med. 2026;394(17):1757-1759. doi:10.1056/NEJMc2516079.
2. Systematic review of platelet-rich plasma for degenerative meniscus tears. Journal of Cartilage and Joint Preservation. 2026. Available at: https://www.cartilagejournal.org/article/S2667-2545(26)00001-6/fulltext.
Medical Disclaimer: This content is for educational purposes only and does not substitute for the medical advice of a physician. Always consult your healthcare provider before beginning any new treatment program. The information presented reflects the opinion of Dr. Jeffrey Peng and does not represent the views of his employers or affiliated hospital systems.
Comments